Creon DR 36,000 unit capsule UU 100S

Ended Awarded

Contract number
SPE2DR26F5WSY
Awardee
Awarding agency
Obligated
$1,916

Award facts

Contract value 100% obligated
$1,916.10 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $1,916.10 delivery order to AmerisourceBergen Drug Corp on July 15, 2026, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy).

Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of July 16, 2026. No set-aside was used. The source does not identify the parent vehicle by name, though AmerisourceBergen holds position on multiple DLA Troop Support Medical indefinite delivery contracts.

Quick answers

Who was awarded contract SPE2DR26F5WSY?

SPE2DR26F5WSY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 15, 2026.

How much is contract SPE2DR26F5WSY worth?

The government has obligated $1,916 on SPE2DR26F5WSY.

Is contract SPE2DR26F5WSY an order under another contract?

Yes. SPE2DR26F5WSY is a delivery order under SPE2DR25D2105, an indefinite delivery contract.

Was contract SPE2DR26F5WSY competed?

The extent of competition for SPE2DR26F5WSY was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award